Today the EU-consortium SYMPATH starts recruitment for a Phase I study of a Parkinson's vaccine candidate called AFFITOPE PD03A. This vaccine is one out of a designated pool of promising vaccine candidates based on AFFiRiS' ...
Researchers at the University of Adelaide are conducting world-first modelling of a range of naturally occurring molecules in the hopes of finding a perfect match that could one day be used in a new drug to help treat or ...
New Zealand dairy giant Fonterra bungled its response to a food contamination scare because it was more concerned with market share than public safety, an official inquiry found Tuesday.
The number of people dying from malaria has almost halved since 2000, although progress in west Africa risks being reversed by the Ebola outbreak, the World Health Organization said Tuesday.
Angiochem, a clinical stage biotechnology company creating and developing drugs that cross the blood-brain barrier, today announced the publication in Molecular Cancer Therapeutics demonstrating that ANG4043, a peptide-monoclonal ...
Healthy, elderly research participants who report being more sleepy and less rested have higher levels of amyloid deposition in regions of the brain that are affected in Alzheimer's disease, according to a report presented ...
Abnormalities in the prefrontal cortex and related brain areas are observed in adolescents who have attempted suicide, according to a report today at the American College of Neuropsychopharmacology annual meeting in Phoenix ...